CorrespondencePembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia
References (14)
- et al.
Gestational trophoblastic disease
Lancet
(2010) - et al.
Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome
Gynecol Oncol
(2015) - et al.
Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study
Lancet
(2009) - et al.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Lancet
(2016) - et al.
Maternal allo-recognition of the fetus
Fertil Steril
(2017) - et al.
A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
Br J Cancer
(2007) - et al.
Survival of women with gestational trophoblastic neoplasia and liver metastases: is it improving?
J Reprod Med
(2012)
There are more references available in the full text version of this article.
Cited by (131)
Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets
2024, Gynecologic OncologyPlacental-site trophoblastic tumor with bone metastasis: A diagnostic and therapeutic challenge
2023, Gynecologic Oncology ReportsCombined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case report
2023, Gynecologic Oncology ReportsA case of complete remission of intractable gestational choriocarcinoma with subsequent chemotherapy after pembrolizumab
2023, Taiwanese Journal of Obstetrics and Gynecology
© 2017 Elsevier Ltd. All rights reserved.